8.610USD-2.77%Mkt Cap: 2.19B USDP/E: —Last update: 2026-06-01
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuramini…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap2.19B USD
Enterprise Value2.88B USD
Revenue (TTM)885.72M USD
Gross Profit855.76M USD
Net Income (TTM)263.86M USD
Revenue/Share4.059 USD
Last Price8.610 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees435
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS09058V1035
Valuation
P/E (Trailing)—
P/E (Forward)13.10
PEG9.39
EV/EBITDA8.84
EV/Revenue3.26
P/S2.56
P/B-4.09
EPS (TTM)-1.77
EPS (Forward)0.68
52W Range
6.00049% of range11.31
52W High11.31 USD
52W Low6.000 USD
Profitability
Gross Margin97.82%
Oper. Margin-2.45%
EBITDA Margin36.86%
Profit Margin30.16%
ROE-221.45%
ROA51.32%
Growth
Revenue Growth7.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF347.37M USD
CapEx (TTM)2.47M USD
FCF Margin29.85%
FCF Yield12.07%
Net Debt619.68M USD
Net Debt/EBITDA1.90
Balance Sheet
Debt/Equity-3.68
Current Ratio1.91
Quick Ratio1.78
Book Value/Sh-2.1800 USD
Cash/Share0.9380 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)21.30 USD
Target Range13.00 USD – 32.00 USD
# Analysts10
Ownership
Shares Out.254.16M
Float220.86M
Insiders1.15%
Institutions100.93%
Short Interest
Short Ratio7.7d
Short % Float14.31%
Short % Out.14.21%
Shares Short36.11M
Short (prev mo.)38.53M
Technical
SMA 509.184 (-6.2%)
SMA 2007.921 (+8.7%)
Beta0.57
S&P 52W Chg27.94%
Avg Vol (30d)4.21M
Avg Vol (10d)4.23M
Technical Indicators
RSI (14)48.9
MACD-0.0685
MACD Signal-0.0776
MACD Hist.+0.0091
BB Upper9.596 USD
BB Middle8.902 USD
BB Lower8.209 USD
BB Width15.58%
ATR (14)0.4212 USD
Vol Ratio (20d)0.34x